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Introduction
Complex interplay between genetic and environmental 
factors defines the functional phenotype of living organisms. 
Integration of these internal and external cues at a single gene 
level is achieved through combinatorial regulation of gene 
expression at both transcriptional and post-transcriptional 
levels. It has been well established that most genes are targeted 
by multiple transcription factors acting through a number of 
separate enhancer sites or in an interdependent manner from 
shared enhancers.1 Moreover, the stability of the produced 
mRNAs and their translation can be affected at the post-
transcriptional level by multiple factors such as regulatory 
RNA-binding proteins (RBPs), often expressed in a cell type-
specific manner.2 As our understanding of the complexity of 
the multiple layers of gene regulation is rapidly advancing, it is 
becoming increasingly important to estimate the contributions 
of individual regulators on the final output simultaneously 
and predict the outcomes of this combinatorial regulation. 
Development of quantitative systems biology models helps to 
integrate the multiple levels of gene regulation.3
Eukaryotic miRNAs, a considerably large class of non-coding 
regulatory RNA molecules, have become recognized as crucial 
factors directing gene expression and development.4 These 
transcripts derive from endogenous inter- or intragenic miRNA 
genes and are generally transcribed by canonical transcription 
machinery.5 miRNAs have large cohorts of potential targets with 
as much as 60% of the transcriptome predicted to be targeted.6 
Importantly, most unique miRNA families can share mRNA 
targets and a shorter distance of binding between miRNAs has 
been shown to play a positive role in advancing the repressive 
effect of multiple miRNAs on one target.7-9 Different approaches 
have suggested that miRNAs efficiently render robustness into 
the patterns of protein expression through participation in various 
network motifs together with TFs and their common target 
genes.10-12 This type of control is extremely important during 
cellular differentiation and commitment—in order to rapidly 
react to discrete but abundant signals that drive differentiation, 
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MicroRNas (miRNas) regulate gene expression directly through base pairing to their targets or indirectly through 
participating in multi-scale regulatory networks. Often miRNas take part in feed-forward motifs where a miRNa and a 
transcription factor act on shared targets to achieve accurate regulation of processes such as cell differentiation. here 
we show that the expression levels of miR-27a and miR-29a inversely correlate with the mRNa levels of lipoprotein 
lipase (Lpl), their predicted combinatorial target, and its key transcriptional regulator peroxisome proliferator-activated 
receptor gamma (Pparg) during 3T3-L1 adipocyte differentiation. More importantly, we show that Lpl, a key lipogenic 
enzyme, can be negatively regulated by the two miRNa families in a combinatorial fashion on the mRNa and functional 
level in maturing adipocytes. This regulation is mediated through the Lpl 3′UTR as confirmed by reporter gene assays. In 
addition, a small mathematical model captures the dynamics of this feed-forward motif and predicts the changes in Lpl 
mRNa levels upon network perturbations. The obtained results might offer an explanation to the dysregulation of LPL 
in diabetic conditions and could be extended to quantitative modeling of regulation of other metabolic genes under 
similar regulatory network motifs.
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various feedback and feed-forward mechanisms must provide 
specificity and sensitivity on the post-transcriptional level.
One of the cellular differentiation processes with important 
implications on overall human health is adipogenesis. Unbalanced 
energy homeostasis is directly connected to the volume and 
endocrine signaling of the adipose tissue.13 At high excess energy 
intake the subcutaneous and, more importantly, the abdominal 
fat deposits expand acquiring different problematic characteristics 
such as altered secretion of adipokines, saturated lipid storage 
capacity, and flooding of the systemic circulation with free fatty 
acids, resulting in insulin resistance.14 The consequences of these 
systematic fluctuations can come to, among other problems, 
hypertension, hyperlipidemia, and hyperglycemia, all symptoms 
of the metabolic syndrome, a condition that is associated with 
coronary heart disease and increased mortality.15
In the early stages of adipogenic commitment, key 
transcription factors such as CCAAT/enhancer binding proteins 
β and δ (C/EBPβ and δ) and the glucocorticoid receptor 
(GR) induce the activation of peroxisome proliferator-activated 
receptor γ (PPARγ), a nuclear receptor generally referred to as 
the master regulator of adipogenesis.16-18 PPARγ, together with 
its primary target C/EBPα, proceed to guide the cells toward 
an adipogenic phenotype through activation of target genes. 
Many of them have been identified by activating PPARγ with 
its synthetic agonists (thiazolidinediones) that have been used for 
the treatment of type 2 diabetes.19 The primary PPARγ targets 
include many genes important for triglyceride uptake and storage 
such as adipocyte protein 2 (aP2), Aquaporin 7 (Aqp7), glycerol 
kinase (GK ), scavenger receptor (CD36 ), and lipoprotein lipase 
(Lpl), the last encoding an enzyme crucial for hydrolysis of very 
low density lipoproteins (VLDL) and chylomicrons.20
LPL is a 55-kDa glycoprotein, mainly synthesized in parenchymal 
cells, such as adipose and muscle tissue, and transported to the 
luminal surface of the surrounding vascular endothelium. The 
enzyme is active as a non-covalent homodimer and bound to the 
endothelium via heparin sulfate proteoglycans.21 LPL-mediated 
hydrolysis of triglyceride-rich lipoproteins is important for the 
rapid clearance of post-prandial lipid loads, thereby providing 
free fatty acids used for storage and energy metabolism and also 
building material for the high-density lipoprotein (HDL) particles. 
In addition, LPL transforms large triglyceride-rich lipoproteins 
into remnant lipoproteins and low-density lipoproteins (LDL).22 
The lipolytic function of LPL is tightly regulated by a number 
of co-factors. The presence of apolipoprotein C-II in plasma, for 
instance, is necessary for lipase activation while apolipoprotein 
C-III is inhibiting its lipolytic activity.23,24 LPL activity varies 
greatly between individuals, but the factors influencing LPL 
expression are incompletely understood. A PPAR response element 
was identified in the human LPL promoter25 and polymorphism 
of PPARγ-2 is accompanied by 20–35% lower plasma LPL 
activity.26 In addition, also a sterol regulatory binding element 
(SREBP) has been identified in the LPL promoter.27 Moreover, 
during adipogenesis, LPL can be regulated by insulin at post-
transcriptional and post-translational levels.28
Consistently, the adipogenic cascade is stringently controlled 
at the post-transcriptional level. Among other post-transcriptional 
regulators, miRNAs play a prominent role during adipocyte 
differentiation. The formation of white adipose tissue in vivo 
and differentiation of 3T3-L1 adipocytes in vitro both require 
miRNA expression.29,30 In addition to promoting differentiation, 
multiple miRNAs prevent unwanted differentiation and maintain 
pre-adipocytes. The miR-27 family has been shown to target 
Pparg mRNA in pre-adipocytes, and thereby, its downregulation 
is necessary for initiating terminal differentiation.31-33 Similarly, 
miR-27 family members are drastically reduced in the beginning 
of osteoblast maturation but are later upregulated through 
feed-back mechanisms to support osteocyte mineralization,34,35 
suggesting a wider role for miR-27 family in mesenchymal 
lineage differentiation.
Another miRNA family implicated in mesenchymal 
differentiation is the miR-29 family. It is dynamically regulated 
during osteoblastogenic differentiation and shown to primarily 
affect the expression of multiple collagen genes as well as inhibit 
osteogenic repressors.36 The role of miR-29 family members 
during adipogenesis has not yet been elucidated, although they 
are expressed at significant levels in the 3T3-L1 adipocyte cell 
line37 and other insulin-sensitive tissues where they regulate 
insulin signaling and become upregulated upon insulin 
resistance.38
In order to further elucidate the dynamic multilevel 
regulatory events occurring during adipocyte differentiation, we 
investigated combinatorial miRNA regulation of the Lpl gene. 
We show that Lpl can be regulated by two miRNAs, miR-27a and 
miR-29a, in mouse 3T3-L1 cells and downregulation of these 
miRNAs during differentiation allows the full extent of PPARγ-
driven induction of Lpl in adipocytes. Forced expression of both 
miRNAs in 3T3-L1 adipocytes represses Lpl mRNA levels, and 
importantly, decreases the secreted enzymatically active LPL 
protein. Based on our newly described interactions and existing 
literature on multilevel regulation of LPL expression, we construct 
a quantitative mathematical model of LPL regulation during 
adipogenesis that can predict the outcomes upon changes in the 
regulatory edges. The principles of this model could be extended 
to regulation of other genes under multilevel combinatorial 
regulation of transcription factors and miRNAs.
Results
Lpl is a putative combinatorial target of miR-27 and miR-29 
miRNA families
With the aim to study combinatorial miRNA regulation 
in differentiating mouse adipocytes, we chose to focus on 
miRNA families miR-27 and miR-29. Both members of the 
miR-27 family, miR-27a and miR-27b, have been shown to 
be abundantly expressed and become downregulated during 
mouse and human adipocyte differentiation and are capable 
of inhibiting adipogenic differentiation.31-33,39,40 Similarly, 
miR-29 family member miR-29a is abundantly expressed and 
downregulated in mature human adipocytes.40 In addition, 
members of both miRNA families exhibit increased expression 
levels in different tissues of diabetic rat models and become 
induced in mouse 3T3-L1 adipocytes at hyperglycemic 
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conditions.38,41 Taken together, the existing data suggest that 
both miRNA families could play important roles in insulin-
sensitive tissues, and in particular, in adipose tissue.
In order to identify putative shared target genes of the two 
miRNA families, we obtained lists of predicted conserved 
targets for the two families from TargetScanMouse6.1. miR-
27 and miR-29 are both predicted to target > 700 mRNAs in 
mouse, 144 of which are potentially shared (Fig. 1A). Since 
miRNAs generally repress their targets and the miRNAs in 
question are downregulated during adipogenesis, their targets 
are expected to become upregulated in parallel. To further 
narrow our list of possible real targets in the adipose tissue, 
we used publicly available mRNA microarray data for murine 
3T3-L1 adipocyte differentiation.42 Analysis of these data 
yielded 962 mRNAs showing more than 2-fold upregulation 
by day 7 of differentiation. Overlapping the predicted shared 
targets of miR-27 and miR-29 with these upregulated mRNAs 
identified six putative shared targets of miR-27 and miR-29 
in mouse adipocyte differentiation: Dot1l, Larp4, Lpl, Pdhx, 
Pitpnm2, and Qk (DOT1-like, histone H3 methyltransferase 
[S. cerevisiae]; La ribonucleoprotein domain family, member 4 ; 
Lipoprotein lipase ; Pyruvate dehydrogenase complex, component 
X; Phosphatidylinositol transfer protein, membrane-associated 2, 
and Quaking, respectively).
Figure 1. Identifying putative adipogenic target genes for miR-27 and miR-29 families. (A) Overlapping gene lists of all putative miR-27 family target 
genes (907), all putative miR-29 family target genes (828) and ≥ 2-fold upregulated adipogenic mRNa transcripts during 3T3-L1 differentiation42 reveals 
144 shared target candidates between the miRNa families, six of which are induced during differentiation. all predicted target gene lists were gener-
ated with Targetscan6.1.57 (B) Gene structure of murine Lpl with further overview of the 3′UTR and miRNa-binding seed sites. Lpl has an ORF of roughly 
4000 nt consisting of nine exons of the coding seqence (red boxes) and a long last exon (orange box) corresponding to the regulatory 3′UTR that consti-
tutes more than half of the mRNa (2426 nt). The miR-27 and miR-29 family 7 nt seed sites are both situated toward the end of the 3′UTR and also carry a 
complementary a-U base pairing site at the first nt in the 5′-end of the miRNas.
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One of these targets, Lpl, the aforementioned critical enzyme for 
triglyceride uptake, belongs to the cohort of highest induced genes 
in adipocyte differentiation and is a primary target of PPARγ.25 
Therefore, we chose to focus on Lpl for downstream analysis. The 
predicted binding sites for miR-27 and miR-29 seed sequences are 
located at the 3′ end of the Lpl-3′UTR starting at positions 1840 
and 2264, respectively, i.e., some 400 nt apart (Fig. 1B).
Taken together, from the 144 predicted shared targets of 
miR-27 and miR-29, six are upregulated during adipocyte 
differentiation. In addition, Lpl, the most responsive of these 
targets, is a known primary target of PPARγ, and thereby, also a 
putative secondary target of miR-27.
miR-27a and miR-29a expression levels 
are inversely correlated with Lpl expression 
during mouse adipogenesis
miR-27a and miR-27b are transcribed as 
part of two separate miRNA clusters (miR-
23a~27a~24-2 and miR-23b~27b~24-1) 
located in miRNA genes on chromosomes 
8 and 13, respectively. Likewise, there are 
two different miRNA clusters giving rise to 
miR-29 family members miR-29a, miR-29b, 
and miR-29c (miR-29b-1~miR-29a and miR-
29b-2~miR-29c) located on chromosomes 
6 and 1, respectively. To distinguish which 
of these miRNA genes are more actively 
transcribed in pre-adipocytes and affected by 
transcriptional repression during adipocyte 
maturation, we analyzed existing ChIP-
Seq data of epigenomic characterization of 
mouse 3T3-L1 adipocyte differentiation 
(Fig. S1).42 As indicated by the levels of 
histone modifications like histone H3 lysine 
27 acetylation (H3K27ac), a marker for 
active enhancers, and histone H3 lysine 4 
trimethylation (H3K4me3), a marker for 
transcription start sites, the loci coding for 
miR-23a~27a~24-2 and miR-29b-1~miR-29a 
show much more transcriptional activity 
than the respective loci coding for miR-
23b~27b~24-1 or miR-29b-2~miR-29c in 
pre-adipocytes. Moreover, both loci show 
some reduction in the histone marks linked 
to transcriptional activity already at day 2 
of differentiation and exhibit clear decrease 
by day 7. Based on these results, we decided 
to focus our analysis on clusters miR-
23a~27a~24-2 and miR-29b-1~miR-29a, 
and in particular, on miR-27a and miR-29a 
as cluster members with unique sequences 
undergoing downregulation during adipocyte 
differentiation.
In order to compare the expression 
dynamics of miR-27a and miR-29a, and 
their putative targets, we performed three 
independent differentiation time courses of 
3T3-L1 cells and extracted RNA every 24 
h (Fig. 2). Subsequently, the expression levels of the miRNAs 
as well as their putative target Lpl were analyzed. In addition, 
we also quantified the expression of Pparg, a known target 
of miR-27a and the main transcriptional regulator of Lpl 
expression. Interestingly, the two miRNAs showed a highly 
similar expression profile in each differentiation experiment 
(Fig. 2) with only modest or no decrease at the beginning of the 
differentiation until day 2 and with a stronger reduction from day 
3 on down to 15–40% of the original levels in pre-adipocytes, 
depending on the differentiation. This downregulation appeared 
dynamic with some increase again toward the end of the time 
Figure  2. expression profiles of Lpl, Pparg, miR-27a, and miR-29a during 8 days of 3T3-L1 
mouse pre-adipocyte maturation. The levels of mature mRNas and miRNas were quantified 
with gene specific primers and TaqMan probes, respectively, during induced adipogenesis of 
8 d in the mouse 3T3-L1 cell line. (A–C) Individual panels depict the relative expression profiles 
during adipogenesis in three independent differentiation experiments (Differentiations 1–3) 
for Lpl, Pparg, miR-27a, and miR-29a. Measured mRNa expression values were normalized to 
Rpl13a mRNa and miRNa values to U6 small nuclear RNa (snRNa) levels. all given data sets 
are normalized to highest data set value of each sample cohort that is depicted as relative 1.
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course. With both miRNAs showing very comparable profiles, 
it is likely that the expression of these miRNAs is regulated in 
a highly coordinated manner. However, treating the confluent 
pre-adipocytes with individual differentiation components alone 
did not reveal strong downregulation of either of the miRNAs 
(data not shown), suggesting that they are under combinatorial 
regulation of multiple factors.
Importantly, also the expression profiles of Pparg and its 
target gene Lpl showed similar expression dynamics and inverse 
expression levels with the tested miRNAs. Both mRNAs 
showed modest increase until day 2 of differentiation, followed 
by a stronger induction from day 3 on, and reaching the 
maximum levels between day 5 and day 6, depending on the 
differentiation. Moreover, the mRNAs decreased again toward 
the end of the time course in parallel with the modest increase 
measured for the miRNAs. The differentiation efficiency 
was controlled by Oil Red O staining on day 0 and day 8, 
indicating generally > 90% differentiation efficiency by day 8 
of differentiation (Fig. S2).
In summary, miR-27a and miR-29a are expressed in a highly 
coordinated and dynamic manner during mouse adipocyte 
differentiation and show inverse expression patterns to those 
of Pparg and Lpl. This suggests that the miRNAs might serve 
to prevent an unwanted upregulation of Pparg or Lpl in pre-
adipocytes and regulate their induction during differentiation.
miR-27a, miR-29a, and Lpl have long half-lives
In order to better understand the dynamics of the measured 
miRNAs and mRNAs, we estimated the stability of the tested 
transcripts. As a control mRNA known to have a short half-life, 
we included Cebpa, another primary target gene of PPARγ coding 
for an important regulator of adipogenesis.43 To get an overview 
of the stability of the miRNAs and mRNAs, transcription in 
D0 pre-adipocyte cells was blocked by actinomycin D (ActD) 
for up to 10 h and RNA samples were collected at intermediate 
Figure 3. mRNa and miRNa stability in 3T3-L1 pre-adipocytes. confluent 3T3-L1 pre-adipocytes were treated with actD on day 0 to inhibit transcription 
or with DMsO as the vehicle control. Total RNa was harvested after 2, 4, 8, and 10 h of treatment. Levels of (A) Lpl, Pparg, and Cebpa and (B) miR-27a and 
miR-29a were quantified by RT-qPcR and normalized to (A) Rpl13a mRNa levels or (B) U6 snRNa levels that were not affected by treatment or vehicle. 
each time point value is calculated relative to vehicle DMsO that is set to 1 (indicated by the dashed line). Data indicate the mean expression values of 
three independent experiments and the error bars represent seM. One sample t test determined the significance of downregulation in response to actD 
treatment (*, P < 0.05; **, P < 0.01).
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Figure 4. Regulation of Lpl and its lipase activity by miR-27a and miR-29a. (A) The 3′UTR of the Lpl gene was cloned in full-length into the psichecK-2 
dual-luciferase reporter plasmid immediately downstream of the Renilla luciferase reporter gene (psichecK-2-Lpl-3′UTR). The psichecK-2-Lpl-3′UTR or 
empty psichecK-2 control vector was co-transfected with 25 nM of miR-27a mimics, miR-29a mimics, or scrambled negative control siRNa (sicontrol) 
into heK293T cells. cell lysis was performed 24 h after transfection, followed by a quantitative luciferase assay. Data are presented as a ratio of Renilla 
over firefly luciferase, calculated relative to sicontrol that is set to 1 (indicated by the dashed line). (B) The psichecK-2-Lpl-3′UTR was co-transfected into 
heK293T cells as in panel a with 75 nM of scrambled control LNa inhibitor, miR-27a-specific LNa-inhibitor or miR-29a-specific LNa-inhibitor together 
with 25 nM of miR-27a mimics or miR-29a mimics, respectively. cell lysis was performed 24 h after transfection, followed by a quantitative luciferase 
assay. Data are presented as a ratio of Renilla over firefly luciferase, calculated relative to LNa-inhibitor alone that is set to 1 (indicated by the dashed line). 
(C–E) six days differentiated 3T3-L1 cells were transfected with 25 nM of miR-27a mimics, miR-29a mimics, with both miRNas or with scrambled negative 
control siRNa (sicontrol). cells were harvested 24 h post-transfection and total RNa was extracted. changes in mRNa expression levels for (C) Pparg, (D) 
Cebpa, and (E) Lpl were quantified by RT-qPcR. all measured expression values were normalized to Rpl13a mRNa and presented as relative to sicontrol 
that is set to 1 (indicated by the dashed line). (F) effect of miR-27a and miR-29a overexpression on secreted functional LPL enzyme. six days differenti-
ated 3T3-L1 cells were transfected with 50 nM miR-27a mimics, miR-29a mimics, scrambled negative control siRNa (sicontrol), or Pparg-specific siRNa 
(siPparg) that served as a positive control. Medium from transfected samples was collected 24, 48, and 72 h post-transfection and subjected to an LPL 
enzyme-activity assay. all measured lipase activity values are presented as relative to sicontrol that is set to 1 (indicated by the dashed line). In all panels 
the data indicate the mean expression values of three independent experiments and the error bars represent seM. One sample t test (A and C–F) or the 
student t test (B) determined the significance of changes in response to miRNa overexpression or their inhibition (*, P < 0.05; **, P < 0.01; ***, P < 0.001).
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time points. As previously reported,44,45 both 
Pparg and Cebpa showed a very fast decrease 
following the ActD treatment with less than 
25% of the total mRNA remaining after 8 h 
and further decreasing by 10 h when compared 
with the DMSO-treated control samples 
(Fig. 3A). On the contrary, Lpl remained at 
comparable levels to the control samples by the 
10 h time point, suggesting a > 10 h half-life 
for Lpl in 3T3-L1 cells.
Similarly to Lpl, miR-29a and miR-
27a remained largely unaffected after 
10 h of transcriptional blocking (Fig. 3B), 
suggesting they possess long half-lives typical 
for miRNAs. This also fits the dynamics 
of their downregulation during adipocyte 
differentiation where they are reduced below 
50% only by day 4 of differentiation (Fig. 2), 
although their transcriptional repression is 
initiated already earlier (as indicated by the 
epigenetic data and primary miRNA levels; 
Fig. S1 and data not shown, respectively).
Lpl-3′UTR mediates the repression by 
miR-27a and miR-29a
To confirm that Lpl mRNA repression 
by miR-27a and miR-29a can indeed be 
mediated through Lpl-3′UTR, we performed 
reporter gene assays using a Renilla luciferase 
reporter gene with the complete Lpl-3′UTR 
cloned downstream of the coding sequence in 
a psiCHECK-2 plasmid (psiCHECK-2-Lpl-
3′UTR). The psiCHECK-2-Lpl-3′UTR, or 
an empty psiCHECK-2 vector as control, were 
transfected into HEK293T cells together with 
miR-27a, miR-29a, or scrambled siRNA as 
control (siControl). The luciferase activity was measured 24 h post-
transfection. As shown in Figure 4A, both miR-27a and miR-29a 
could specifically repress the psiCHECK-2-Lpl-3′UTR activity by 
more than 50% when compared with the cells similarly transfected 
with siControl. As a side effect, miR-27a had also some repressive 
effect on the empty vector control while miR-29a affected only the 
vector with Lpl-3′UTR. Nonetheless, inclusion of Lpl-3′UTR led 
to stronger repression by miR-27a, arguing that the repression of 
the reporter by both of the miRNAs can be mediated through the 
Lpl-3′UTR, while miR-27a can also directly or indirectly repress 
psiCHECK-2 basal expression. Similar results were also obtained 
using HeLa cells (data not shown).
Moreover, to further test the specificity of the targeting of 
Lpl-3′UTR by the miRNAs, we performed the co-transfections 
again in the presence of complementary miRNA-specific 
LNA-inhibitor molecules, or a scrambled control inhibitor. 
Importantly, both miRNAs were able to repress the reporter 
containing Lpl-3′UTR in the presence of the control LNA-
inhibitor to similar extent as above, but this repression was fully 
abolished in both cases by the inclusion of the miRNA-specific 
inhibitors (Fig. 4B). Thus, based on these results, both miR-27a 
and miR-29a are capable of repressing Lpl, and this repression is 
mediated through Lpl-3′UTR.
Effect of miR-27a and miR-29a overexpression on Pparg, 
Cebpa, and Lpl during 3T3-L1 adipogenesis
To investigate the effect of the miRNAs on the endogenous 
mRNAs of Pparg, Cebpa, and Lpl in differentiating adipocytes, 
overexpression experiments were performed in adipocytes. Six days 
differentiated 3T3-L1 adipocytes were transfected with either of 
the individual miRNA mimics or combinatorially with the two 
miRNA mimics and harvested 24 h post-transfection. SiControl-
transfected cells served as a control. As depicted in Figure 4C, 
miR-29a had no effect on the levels of the endogenous Pparg, while 
miR-27a had a significant effect of approximately 40% decrease 
in Pparg levels. This is consistent with previous reports that Pparg 
is a primary target of the miR-27 family.31-33 In keeping with the 
fact that Cebpa is a primary target of PPARγ and highly dependent 
on its transcriptional activity, Cebpa was also significantly 
downregulated upon miR-27a overexpression but remained at 
elevated levels upon miR-29a overexpression (Fig. 4D).
Overexpression of both miR-27a and miR-29a caused some 
downregulation of Lpl mRNA already 24 h post-transfection, 
Figure  5. Graphical network representation of the model for LPL regulation. Key compo-
nents and interactions of the developed ordinary differential equation model depicted in 
a simplified sBGN notation.63 The model comprises 10 states, 24 reactions, and 22 param-
eters. states are represented as rectangles. Yellow background indicates protein (ceBPa, 
PPaRG), orange mRNa (Cebpa, Pparg, Lpl), and green miRNa (miR-27a, miR-29a). The state 
names were used in the systems Biology Toolbox2 model (see supplementary Materials). 
The variable names of the formed miRNa–mRNa complexes as used in the mathematical 
model are given in the attached small rectangle. Model inputs (Xc, Xm27, Xm29) are shown 
as oval shapes where orange-to-yellow gradient background indicates that the exact under-
lying molecular mechanism is not known or as a green circle (Rosi). arrows represent reac-
tions with the corresponding reaction name as used in the model. For details on model 
development, implementation, and model parameters, see Material and Methods and 
supplementary Materials.
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with the most significant repression occurring upon equimolar 
combinatorial transfection of both miRNAs (Fig. 4E). The 
exact extent of the mRNA repression could depend on the 
differentiation level of the transfected cells. Indeed, the repression 
of Lpl by miR-29a varied considerably between experiments 
with some showing 2–3-fold stronger repression than others, 
effectively causing unusually high variation at these conditions.
Taken together, both miR-27a and miR-29a are capable of 
repressing endogenous Lpl mRNA levels in 3T3-L1 adipocytes 
while only miR-27a can repress Pparg and thereby indirectly its 
primary targets.
miR-27a and miR-29a overexpression leads to lowered lipase 
activity of the adipocyte-secreted LPL enzyme
To confirm that the observed repression of Lpl upon increased 
miRNA levels also leads to repression of lipase activity of the 
secreted protein, we measured the enzymatic activity of 
secreted LPL. This was achieved by transfecting 6 days 
differentiated 3T3-L1 adipocytes with miRNA mimics or 
siControl and collecting the culture media 24, 48, and 72 
h post-transfection for a lipase activity assay. As a positive 
control we knocked-down PPARγ, which led to a significant 
decrease in LPL activity already after 48 h of knockdown 
(Fig. 4F). Similarly, the miRNAs had no effect on LPL 
activity yet at 24 h. But consistently with their direct targeting 
of Lpl mRNA starting from 24 h on, the increased miRNA 
levels caused a decrease in measured enzymatic activity of 
the secreted LPL by 48 h, followed by a further significant 
decrease by 72 h post-transfection. This argues that targeting 
of Lpl by miRNAs miR-27a and miR-29a can lead to lowered 
functional activity of the LPL enzyme, and are likely to lower 
triglyceride uptake by the adipocytes. However, further 
experiments are needed to test the impact of the miRNAs on 
triglyceride levels of differentiated adipocytes.
Mathematical modeling of the miRNA regulation 
network of Lpl
Summary of the main interactions governing 
the regulation of Lpl in adipocyte differentiation by 
PPARγ, miR-27a and miR-29a based on the obtained 
experimental data and literature is depicted as a graphical 
network representation in Figure 5. In this summary, the 
differentiation initiation by the external signals (Xc) leads 
to a transcriptional cascade that triggers the expression of 
CEBPα, which in turn, increases the levels of PPARγ and 
leads to a regulatory feed-forward loop between the two 
transcription factors. In parallel, the repression of the two 
miRNAs, miR-27a and miR-29a, is initiated by for-now-
unknown external signals (Xm27 and Xm29), enabling 
the ongoing upregulation of PPARγ, a primary target of 
miR-27a. After 2 days of differentiation, PPARγ agonist 
rosiglitazone (Rosi) is included in the differentiation 
cocktail, allowing the full extent of PPARγ activation 
and induction of its target genes. These include Lpl that 
has been expressed at low levels in the pre-adipocytes and 
targeted to RISC-like complexes by the abundant miR-
27a and miR-29a. The concomitant downregulation of the 
miRNAs allows for strong upregulation of Lpl and proper 
establishment of the adipogenic phenotype.
To investigate if the obtained experimental data are already 
sufficient to generate a consistent and quantitative description of 
the overall behavior of the system, a small mathematical model 
was developed comprising the key elements and interactions. 
The model parameters were fitted to the experimental data. The 
main questions to be answered with the model are, if (1) such 
a simple principal model allows capturing the key dynamics of 
miRNA degradation and expression onset, (2) which network 
structures are responsible for the observed switching behavior, 
and (3) to carve out the specific characteristics of the individual 
time courses. Thereby, we focused especially on differentiation 
1, which shows a sharper onset and the identification of the 
potentially responsible parameters. See the Materials and 
Methods section, as well as Supplementary Materials for details 
Figure 6. Fitting the mathematical model parameters to the three 3T3-L1 dif-
ferentiation time courses. Model fit for three independent adipogenic differen-
tiation time courses (see Fig. 2) and five model states resulting from parameter 
identification in systems Biology Toolbox2 that combined global and local 
parameter estimation algorithms. Black dotted line represents measured 
mRNa levels and red dashed line represents the median of all iterations of the 
model fit within an optimal cost threshold of 1.33-fold of the best obtained 
fit with red solid lines fading up to 68% confidence. Measured mRNa expres-
sion values are normalized to highest mRNa data point and measured miRNa 
expression values are normalized to highest miRNa data point. all axes and 
data points correspond to measured cDNa ratios.
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on modeling, parameter estimation, and in silico predictions. As 
the three measured differentiation time courses showed some 
differences in their dynamics, the mathematical model was 
fitted to all of them independently (Fig. 6). Only a subset of 
the unknown parameters, (nine out of 22) have a low relative 
standard deviation (≤ 30%) and can therefore be considered to 
be practically identifiable (Table S3). Most other parameters 
(exceptions discussed below) have the same mean across the three 
experiments but with a higher relative standard deviation.
Fits were obtained for three experiments, indicating that 
this simple principal model already allows capturing the key 
dynamics of the investigated network, i.e., downregulation 
of the miRNAs and fast onset of the mRNA expression. This 
switch-like nonlinear behavior is due to the positive feedback loop 
linking PPARγ and C/EBPα. Differentiation 1 shows a sharper 
onset (Fig. 6A) compared with the other two differentiations 
(Fig. 6B and C), which is also captured by the mathematical 
model. The basal mRNA production rates of Pparg and Cebpa, 
as well as the miRNA–mRNA complex formation rate constants, 
were estimated to be significantly higher than in the other two 
time courses (Table S3). The increased basal expression of the 
Pparg and Cebpa requires a higher miRNA complex formation 
already in the unstimulated system and forms a system under 
tension, which acts faster once the miRNA levels are decreasing. 
This predicted higher basal mRNA expression for differentiation 
1 was confirmed by RT-qPCR (data not shown).
Figure 7. In silico model predictions of target mRNa level changes in response to miRNa perturbation during Differentiation 1. (A) The fitted model 
predicts (B) overexpression of Cebpa, Lpl, and Pparg when miRNa-target complexes are not forming; (C) downregulation of Cebpa, Lpl, and Pparg when 
miRNa levels remain at Day 0 levels; (D) and strong reduction in Cebpa, Lpl, and Pparg levels (up to 80% for Lpl) when both miRNas miR-27a and miR-29a 
are 2-fold overexpressed at differentiation start. Black dotted line represents measured mRNa levels and the red dashed line represents the median of 
all iterations of the model fit within an optimal cost threshold of 1.33-fold of the best obtained fit, respectively, the median of the predictions obtained 
by using these selected model fits, with red fading up to +/-68% of confidence levels. Measured mRNa expression values are normalized to highest 
mRNa data point and measured miRNa expression values are normalized to highest miRNa data point. all axes and data points correspond directly to 
measured cDNa ratios. confidence intervals are 68% for shown fits.
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Using this established model, 
further in silico investigations 
and predictions were performed 
by simulating the effects of 
disabling miRNA–mRNA 
complex formation, of keeping 
the miRNA levels constant, and 
of overexpressing miRNAs 2-fold 
(Fig. 7; Figs. S3 and S4). Disabling 
miRNA complex formation results 
in an increased and more rapid 
induction of Cebpa, Lpl, and Pparg 
mRNAs during differentiation 
(Fig. 7B; Figs. S3B and S4B), 
while stable or overexpressed 
miRNA levels result in slower and 
decreased mRNA upregulation 
(Fig. 7C and D; Figs. S3C and 
D, S4C and D). Interestingly, in 
each case the model predicts only an 
altered robustness in the response 
of Lpl without fully preventing 
or releasing its expression. All 
three differentiations show this 
same qualitative behavior, although 
the effect is more pronounced for 
the model based on differentiation 
1, as the system under tension is 
more dependent on the miRNAs 
(Fig. 7).
Validation of the model 
predictions for stable overexpression 
or complete deletion of miRNA 
function would require the 
establishment of sophisticated 
cellular systems where the levels 
of the different molecules can be 
accurately controlled. To circumvent 
this issue, we instead predicted the 
impact of a transient combinatorial 
miRNA overexpression on D6 of 
differentiation (Fig. 8), similarly 
to the experiment depicted in 
Figure 4C–E. Interestingly, the 
model predicted a clear reduction 
in the levels of all three tested 
mRNAs in response to the 
increased miRNA levels. The 
predicted reductions were somewhat 
stronger but comparable to those 
previously obtained experimentally 
on day 7 of differentiation, when the 
target mRNAs are highly expressed 
(Fig. 8B). Also, the model was 
accurately predicting the effect to 
be stronger on Lpl than on Pparg or Cebpa.
Figure 8. In silico model predictions of target mRNa level changes in response to transient miRNa over-
expression during Differentiation 1. (A) The fitted model (B) predicts up to 60% reduction in Lpl levels 
and around 40% reduction in Cebpa and Pparg levels when both miRNas are transiently 2-fold overex-
pressed at D6. (C) No significant effect on Cebpa or Pparg levels is predicted when both miRNas are 2-fold 
overexpressed at differentiation start, while Lpl is modestly repressed and delayed in its response. For 
further details, see Figures 7 and 9.
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Figure 9. In silico model predictions and experimental validation of Lpl mRNa level changes in response to transient overexpression of individual miR-
Nas prior to differentiation onset. (A) a bar graph presentation of the in silico predicted relative Lpl expression values for the time point D2 upon over-
expression of either miR-27a or miR-29a. error bars represent upper and lower bounds of the 68% confidence interval of the predictions. (B) The level of 
Lpl mRNa was quantified with gene-specific primers on time point D2 of adipogenesis induced in the mouse 3T3-L1 cell line following either a transient 
transfection of 25 nM sicontrol, miR-27a mimic, miR-29a mimic, or no transfection. Measured expression values were normalized to Rpl13a mRNa and 
presented as relative to no transfection control that is set to 1. The data indicate the mean expression values of three independent experiments and the 
error bars represent seM. One sample t test determined the significance of changes in response to miRNa overexpression (**, P < 0.01).
Encouraged by these results, we set out to test what kind of 
an effect similar transient overexpression of the miRNAs might 
have on the target mRNAs and differentiation when performed 
on day 0, before differentiation onset. In contrast to stable 
overexpression depicted in Figure 7D, the model predicted 
only weak or no downregulation for Pparg and Cebpa, at the 
beginning of the differentiation, which largely disappeared by 
the end of differentiation, consistent with the transient nature 
of the overexpression (Fig. 8C). In case of Lpl, the initial 
downregulation was predicted to be slightly stronger and the 
delayed and reduced induction was maintained also later.
To study the predicted modest impact on Lpl more closely 
and test this prediction experimentally, the model was used to 
predict in silico the impact of the individual miRNAs on Lpl 
upon transient overexpression on day 0 (Fig. 9). As shown in 
Figure 9A, both miRNAs were predicted to be capable of 
reducing Lpl levels by day 2, with miR-29a showing a slightly 
stronger effect than miR-27a. To see if similar results could be 
obtained in vitro upon transient miRNA overexpression, the 
3T3-L1 cells were transfected on day 0 prior to differentiation 
and Lpl mRNA levels were measured on day 2 of differentiation 
(Fig. 9B). While fairly weak, a qualitative behavior of Lpl 
similar to the in silico predictions could be observed following 
the overexpression of the individual miRNAs. Again, miR-29a 
exhibited a stronger effect while the effect of miR-27a was within 
experimental variation (Fig. 9B). However, at later time points, 
the Lpl levels in miRNA-transfected cells reached those of the 
control cells and the overall differentiation was not inhibited 
(Fig. S5). This was also confirmed by Oil Red O staining of 
the differentiated transfected cells, which appeared comparable 
to the control cells in their lipid accumulation (data not shown).
Taken together, this integrated modeling shows that the 
collected literature information and experimental data allow 
generation of a consistent representation of the underlying 
molecular network, in terms of a mathematical description. The 
fitted and predicted dynamical behavior matches the current 
knowledge, including many of the experimental results here, 
although more data needs to be incorporated in order to get a 
fully identifiable model with higher prediction confidence. 
The mathematical model therefore is a good starting point for 
planning further experiments.
Discussion
LPL is a key player in the metabolism of neutral lipids and 
plays an important role in providing triglyceride components 
to various cells. It is also central for successful adipogenesis and 
for maintaining adipose tissue, an organ that is often mistaken 
as a simple storage of lipids. This misconception was unraveled 
stepwise when the transcription factors governing adipogenesis 
were uncovered.46 Several decades of research have been 
dedicated to studying function and regulation of LPL, but its 
exact regulation in health and disease remains to be elucidated 
in detail. The lack of knowledge is reflected by the continuous 
debate whether or not LPL is pro- or anti-atherogenic and under 
what circumstances.47 In addition, LPL has been targeted by 
several drugs to treat either lipid disorders (PPARα agonists), or is 
affected by the glucose-lowering anti-diabetic thiazolidindiones 
(PPARγ agonists).48 All of these attempts, however, yielded mixed 
results in clinical practice, likely due to missing information 
about the versatile function of LPL in cells that were not the 
primary target of the drugs.49,50
Various factors complicate the issue, such as the cell-
autonomous role of LPL, the complex and partly juxtaposed 
enzymatic and non-enzymatic functions of LPL, and the 
combination of both transcriptional and post-transcriptional 
regulation of the molecule.47 In addition to its regulation 
by transcription factors like PPARγ, LPL is recognized as 
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regulated at the post-transcriptional level, a fact reflected 
also by the particularly long 3′UTR of Lpl (Fig. 1B). Indeed, 
already more than two decades ago it was suggested that while 
LPL upregulation during adipocyte differentiation is driven 
especially by increased transcription, its activation by insulin is 
mainly dependent on post-transcriptional activation.28 In line 
with this observation, later work has shown that LPL becomes 
downregulated in the adipose tissue of diabetic rats at the post-
transcriptional level and this downregulation depends on specific 
regions of Lpl 3′UTR.51 It is therefore conceivable that miRNAs, 
which have emerged as the major post-transcriptional regulators 
of most mammalian mRNAs, are also targeting Lpl. Indeed, 
recent studies have separately presented miR-467b and miR-
29a as single regulators of Lpl in steatosis-induced hepatocytes 
and dendritic cells, respectively.52,53 Here we show that miR-
27a and miR-29a clearly determine LPL expression and activity 
in adipocytes and demonstrate that both miRNAs act in a 
combinatorial fashion. Interestingly, both miR-27a and miR-
29a are also among the few miRNAs upregulated in adipocytes 
of diabetic rats,38,41 suggesting that they could play a role in the 
above mentioned decrease of LPL in diabetes.
In addition to targeting Lpl, miR-27a also represses the 
expression of PPARγ, the key transcriptional regulator of Lpl. In 
this way they constitute a coherent feed-forward loop where the 
miRNA regulates multiple transcripts along the same regulatory 
axis and leads to a delay in the response upon a dynamic shift.54 
In order to provide a more systematic overview or simulation of 
various combinatorial factors, we took advantage of a systems 
biology approach of constructing a small mathematical model 
that could be helpful in determining LPL regulation under 
different circumstances and in different target organ systems. 
Our model was able to capture the key dynamics of the studied 
network and allowed the prediction of the effects of elaborate 
perturbations in the network. Interestingly, predicting the effect 
of no downregulation or even upregulation of miRNA levels 
during adipogenesis led only to decreased and delayed response 
of Lpl, and not to a fully inhibited induction, according to the 
model. This is consistent with the general role of type 2 coherent 
feed-forward loops in delaying the target response,54 and with the 
proposed role for miRNAs in buffering the levels of their target 
mRNAs during cell state transitions.55
Curiously, the results from in silico predictions upon transient 
miRNA overexpression suggest that, while efficient in reducing 
the target mRNAs in differentiated adipocytes, the impact 
remains modest when overexpressed in pre-adipocytes—an 
observation that was also confirmed experimentally (Figs. 4C–E, 
8, and 9). A possible explanation could be that in pre-adipocytes 
the expressed target mRNAs are already occupied by the 
abundant endogenous miRNA-complexes, and strong additional 
repression of the target mRNAs is not possible.
In addition to modeling Lpl regulation, our model can be 
extended and modified to analyze other similar network motifs. 
For example, miR-27 family is establishing itself as one of the key 
regulators of lipid metabolism and seems to be targeting multiple 
enzymes along the triglyceride synthesis pathway, in addition to 
LPL.40,56 In the future, combining this type of small models of 
miRNA regulatory networks with large scale metabolic modeling 
might enable predicting the impact of miRNAs on the cellular 
metabolism more accurately.
Materials and Methods
Identification of putative combinatorial targets of mir-27 
and miR-29 families in mouse 3T3-L1 adipocytes
MiRNA target predictions for miR-27 and miR-29 families 
were obtained from TargetScanMouse (Release 6.1)57 and all 
target mRNAs with at least one conserved binding site were 
included in the analysis. A publicly available microarray data set 
of transcriptomic changes during three time points (day 0, 2, 7) 
of mouse 3T3-L1 adipocyte differentiation42 was used to identify 
the mRNAs with at least one probe set upregulated above 2-fold 
by day 7 of differentiation.
Cell culture
The murine pre-adipocyte cell line 3T3-L1 was obtained from 
ATCC and maintained in Dulbecco’s modified Eagle-medium 
supplemented with 10% fetal calf serum (Gibco, 10270-106), 
1% penicillin–streptomycin, and 1% L-glutamine (Lonza, 
DE17-602E, BE17-605E). The cells were kept at 37 °C and 5% 
CO
2
. Pre-adipocytes were differentiated into mature, fat-storing 
adipocytes as previously described.58 Please note that rosiglitazone, 
which is included in the differentiation cocktail from D2 on, can 
lead to some browning of 3T3-L1 adipocytes,59 and thus, the 
presented results may also be true for brite mouse adipocytes. 
In order to stain the lipids in pre-adipocytes and adipocytes, Oil 
Red O solution (Sigma-Aldrich) was used. Briefly, day 0 and 
day 8 adipocytes were fixed in 10% formalin and incubated for 
10 min at room temperature. Then formalin was removed and 
renewed with fresh formalin for at least 1 h. Again formalin was 
removed and adipocytes were rinsed with 60% isopropanol and 
dried. Then Oil Red O solution was added to adipocytes and 
incubated during 10 min at room temperature. Finally Oil Red 
O solution was removed, adipocytes were rinsed with H
2
O and 
imaged. For ActD treatment, the cells were grown to confluency 
and at day 0 treated with 2 μg/ml ActD or an equal volume 
of vehicle control (dimethyl sulfoxide [DMSO]). The human 
embryonic kidney 293T (HEK293T) cell line was maintained in 
RPMI 1640 medium supplemented with 10% fetal calf serum, 
1% penicillin–streptomycin, and 1% L-glutamine and kept at 
37 °C and 5% CO
2
.
miRNA transfections and RNA interference
MiRNA mimics for miR-27a and miR-29a (Thermo 
Scientific Dharmacon, C-310523-05-0005, C-310521-07-0005) 
and a scrambled double-stranded siRNA sequence as control 
(siControl) (Eurogentec, SR-CL000-005) were introduced into 
undifferentiated 3T3-L1 pre-adipocytes prior to differentiation 
using Lipofectamine 2000 (Invitrogen, 11668-019) according to 
the manufacturer’s instructions. MiRNA mimics for miR-27a and 
miR-29a, gene-specific siRNAs against mouse Pparg (siPparg) 
(Thermo Scientific Dharmacon, C-310523-05-0005, C-310521-
07-0005), and a scrambled double-stranded siRNA sequence as 
control (siControl) (Eurogentec, SR-CL000-005) were introduced 
into 6 days differentiated 3T3-L1 adipocytes using Nucleofector 
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II Device (program A-033) and the Cell Line Nucleofector Kit 
L (Lonza, VVCA-1005 KT) according to the manufacturer’s 
instructions. The sequences of the siRNAs are listed in Table S1.
Luciferase reporter assays
The full-length wild-type murine 3′untranslated region 
(3′UTR) of the Lpl gene was synthesized and cloned into the 
psiCHECK-2 vector (Promega) at XhoI/NotI sites downstream 
of Renilla luciferase translational stop codon (DNA2.0 Inc.). 
Empty psiCHECK-2 vector served as a control plasmid.
For the 3′UTR reporter assay, ~90% confluent HEK293T 
cells were co-transfected with 25 nM miR-27a or miR-29a mimics 
or siControl and 200 ng of either of the psiCHECK-2 constructs 
in 12-well plates with Lipofectamine 2000 (Invitrogen, 11668-
019). Twenty-four hours post-transfection, the cells were washed 
with 500 μl of PBS and lysed in 250 μl of passive lysis buffer. Ten 
μl of the lysate was used for measuring the Renilla (RL) and firefly 
(FL) luciferase activities in a FluoStar Optima instrument (BMG 
LABTECH) using the Dual-Luciferase Reporter Assay System 
(Promega, E1960) according to manufacturer’s instructions. 
Samples were quantified in technical duplicates on a 96-well 
plate. Each condition was performed in technical duplicates 
and in three biological replicates. The specific RL activity was 
normalized to the respective FL activity.
miRNA inhibitor transfections
MiRNA mimics for miR-27a and miR-29a (Thermo 
Scientific Dharmacon, C-310523-05-0005, C-310521-07-
0005) together with their respective inhibitor, miR-27a LNA 
inhibitor (Exiqon, 410168-00), or miR-29a LNA inhibitor 
(Exiqon, 410174-00), or a scrambled double-stranded negative 
LNA control (Exiqon, 199020-00) were introduced together 
with 200 ng of the psiCHECK-2-Lpl-3′UTR vector into ~90% 
confluent HEK293T cells in 12-well plates using Lipofectamine 
2000 (Invitrogen, 11668-019) according to the manufacturer’s 
instructions. miRNA mimics were of a final concentration 
of 25 nM, miRNA inhibitors and the control LNA-inhibitor 
were of a final concentration of 75 nM. Cells were lysed 24 h 
after transfection and the lysate used for the Dual-Luciferase 
Reporter Assay System (Promega, E1960) as described above. 
Bioluminescence was quantified in a BioTek SynergyMX 
instrument (BioTek Instruments Inc.).
RNA extraction and cDNA synthesis
3T3-L1 cells were lysed in 1 ml/10 cm2 TRIsure reagent 
(Bioline, BIO-38033) on 6-well culture plates. Total RNA was 
extracted with 200 μl of chloroform, precipitated with 400 μl of 
isopropanol overnight at -20 °C, ethanol-washed and pelleted by 
centrifugation. RNA purity and concentration were measured 
on a NanoDrop2000 spectrophotometer (Thermo Scientific 
Dharmacon). cDNA synthesis was performed with 1 μg of total 
RNA and 0.5 mM dNTPs, 2.5 mM oligo-dT primer, 1 U/
ml RiboLock RNase Inhibitor (Fermentas, EO0384), 10 U/ml 
M-MuLV Reverse Transcriptase (Fermentas, EP0352) for 1 h at 37 
°C. cDNA synthesis was terminated by 10 min incubation at 70 
°C and cDNA diluted to final volume of 400 μl. Please note that 
the total RNA samples used for the time course results presented in 
Figure 2 are same as those used by John et al.58 and can therefore 
be compared with results presented there for other miRNA genes.
Quantitative PCR
Real-time quantitative PCR (qPCR) was performed in an 
Applied Biosystems 7500 Fast Real-Time PCR System using 
Absolute Blue qPCR SYBR Green Low ROX Mix reagent (Thermo 
Fisher Scientific, AB-4323/D). Each 20 μl of PCR reaction 
comprised 5 μl of cDNA template, 5 μl primer pairs (2 μM), and 
10 μl of qPCR SYBR mix. The PCR reaction started with 15 min 
at 95 °C to activate the polymerase and was followed by 40 cycles of 
15 s at 95 °C, 15 s at 55 °C, and 30 s at 72 °C. Post-PCR melt curve 
analysis was used to control the PCR product specificity. Relative 
expression levels were calculated from raw signal intensities within 
each independent experiment using the equation 2-(ΔΔCt), where 
ΔΔCt is (Ct
(target gene)
-Ct
(control gene)
)
tested condition
 – (Ct
(target gene)
-Ct
(control 
gene)
)
control condition
 and Ct is the cycle at which a user-defined signal 
threshold is crossed. Rpl13a gene was used as the stable control gene 
and D0, vehicle control or siControl served as control condition. 
The sequences of the primer pairs are listed in Table S2.
miRNA assays
Mature miRNA sequences were selectively reverse transcribed 
using the TaqMan MicroRNA Reverse Transcription Kit 
(Applied Biosystems, 4366596) and the expression of mature 
miRNA transcripts was quantified with the TaqMan MicroRNA 
Assays (Applied Biosystems, 4440040). All reactions were 
performed according to the manufacturer’s instructions in an 
Applied Biosystems 7500 Fast Real-Time PCR System. Relative 
expression levels were calculated within each independent time 
course experiment using the equation 2-(ΔΔCt), where ΔΔCt is 
(Ct
(target miRNA)
-Ct
(U6 )
)
tested condition
 – (Ct
(target miRNA)
-Ct
(U6 )
)
control 
condition
 and Ct is the cycle at which a user-defined signal threshold 
is crossed. U6 gene was used as the stable control gene and D0 or 
vehicle control served as control condition.
LPL enzyme activity assay
Culture medium of day 6 transfected adipocytes was collected 
24, 48, and 72 h after transfection and 2 μl of the medium 
was used to measure LPL activity. The activity of secreted LPL 
was quantified using the ROAR LPL Activity Assay kit (Roar 
Biomedical Inc., RB-LPL2) according to the manufacturer’s 
instructions in a BioTek SynergyMX instrument (BioTek 
Instruments Inc.). Enzymatic activity upon miRNA mimic 
transfection is presented relative to siControl-tranfected samples.
Mathematical modeling
A small mathematical model using ordinary differential 
equations (ODEs) was constructed, focusing on the core elements 
and interactions of the biological system. Based on literature data 
(and transcription factor binding data), the model comprises as 
core structures a coherent feed-forward loop, as well as a positive 
feed-back loop (see Fig. 5). The feed-forward loop connects miR-
27a to Pparg and Lpl through translational inhibition and PPARγ 
to Lpl through transcriptional upregulation. PPARγ and C/EBPα 
are connected through positive feedback on the transcriptional 
dimension. In addition, miR-29a-dependent translational 
inhibition of Lpl is included, as well as basal production and 
degradation rates for all mRNAs and miRNAs. Four inputs 
are used to mimic the experimental procedure, resulting in an 
increased induction of Cebpa transcription from day 0 to day 2 
(input Xc), a reduced production of miR-27 from day 0 on (input 
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Xm27), and a completely abolished production of miR-29 from 
day 0 on (input Xm29). In addition, rosiglitazone is added at day 
2 to activate PPARγ (input Rosi).
Reaction rates were modeled applying the law of mass action. The 
resulting ordinary differential equation model was implemented in 
the Systems Biology Toolbox2 within the Matlab© framework.60 
The model comprises 10 states, 24 reactions, and 22 parameters. 
See Supplementary Materials for the ODE model (parameters and 
initial conditions from the best fit of differentiation 2) in the unit 
[1/d] and Table S3 for details on parameters. miRNA and mRNA 
half-lives (t
1/2
) were obtained from ActD measurements in D0 pre-
adipocytes and additional literature data43,44 and converted into 
parameters: k
1/2
 = ln2/t
1/2
 (day-1). Consequently, the bounds for 
these parameters were set according to measured half-lives (Table 
S3). Bounds for unknown parameters were set to (0, 1000). The 
miR-27 Lpl complex (Lpl27) formation rate constant was bounded 
to (0, 10) and other miRNA–mRNA complex formation rates 
were allowed to deviate from this rate at most 2-fold, to reflect 
lower miRNA impact compared with other regulations. The effect 
of internal ligands responsible for the PPARγ activation limited to 
50% of the rosiglitazone effect and the production of miR-27 from 
day 0 on (input Xm27) was estimated between (0, 1), meaning 
0–100% of the basal production rate.
All measurements were first normalized to the maximal value. 
In a second normalization step, the relative (and experiment 
specific) differences within mRNA and miRNA expressions were 
taken into account, resulting in different maximal levels for the 
measured states in the interval (0, 1). Within the model, a 100–
1000 fold excess of miRNA over mRNA molecules was assumed. 
The ratio was consecutively estimated.
The model was fitted for estimating the unknown parameters 
and initial conditions using measured time course data for Cebpa, 
Lpl, Pparg, miR-27a, and miR-29a, and a hybrid optimization 
approach within the Systems Biology Toolbox 2 applying first 
a global particle swarm algorithm (pswarmSB)61 followed by 
a local simplex algorithm (simplexSB).62 The estimation was 
initialized with random parameter values (max 2-fold up or 
down from the initial estimate) within the given bounds 400 
times. All fits within an optimal cost threshold of 1.33 times of 
the best optimal cost were extracted. Median and 68% range 
(the range captured by one standard deviation in a normal 
distribution) were plotted with lines indicating 1% steps for the 
obtained fits and model predictions. In silico predictions were 
performed based on all parameter sets fulfilling the optimal 
cost threshold in the respective experiment. For the predictions, 
miRNA complex formation was inhibited by setting the 
complex formation rate constants to 0. Stable miRNA levels 
were modeled by keeping inputs Xm27 = Xm29 = 1 constant 
and 2-fold overexpression was modeled by changing Xm27 = 
Xm29 = 2 from day 0 on and adjusting the state value of the 
miRNAs accordingly.
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